Matches in Wikidata for { <http://www.wikidata.org/entity/Q59334844> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q59334844 description "im November 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q59334844 description "wetenschappelijk artikel" @default.
- Q59334844 description "наукова стаття, опублікована в листопаді 2018" @default.
- Q59334844 name "2562. Re-Appraisal of Aminoglycoside (AG) Susceptibility Testing Breakpoints Based on the Application of Pharmacokinetics–Pharmacodynamics (PK-PD) and Contemporary Microbiology Surveillance Data" @default.
- Q59334844 name "2562. Re-Appraisal of Aminoglycoside" @default.
- Q59334844 type Item @default.
- Q59334844 label "2562. Re-Appraisal of Aminoglycoside (AG) Susceptibility Testing Breakpoints Based on the Application of Pharmacokinetics–Pharmacodynamics (PK-PD) and Contemporary Microbiology Surveillance Data" @default.
- Q59334844 label "2562. Re-Appraisal of Aminoglycoside" @default.
- Q59334844 prefLabel "2562. Re-Appraisal of Aminoglycoside (AG) Susceptibility Testing Breakpoints Based on the Application of Pharmacokinetics–Pharmacodynamics (PK-PD) and Contemporary Microbiology Surveillance Data" @default.
- Q59334844 prefLabel "2562. Re-Appraisal of Aminoglycoside" @default.
- Q59334844 P1433 Q59334844-6E1E7646-C1CA-4B7F-9C9C-C71F6CBC301C @default.
- Q59334844 P1476 Q59334844-9EDF09B6-0D7E-45D4-97E1-F0BB70402438 @default.
- Q59334844 P2093 Q59334844-77598C46-06F3-4F3A-8B3E-D77A48FE28ED @default.
- Q59334844 P2093 Q59334844-8BD0BC83-0A8C-47D2-ABB5-90BCDD3271C2 @default.
- Q59334844 P2093 Q59334844-A4266465-1843-4C39-8095-95B336FDFEC3 @default.
- Q59334844 P2093 Q59334844-A8ADC5AC-0A83-4DC2-A221-6B6C05235FAB @default.
- Q59334844 P2093 Q59334844-B5394DA3-EBDC-4F71-84D3-163F8D7F4BD6 @default.
- Q59334844 P2093 Q59334844-FBDC473A-C6D5-4C73-B7F3-8554D260540C @default.
- Q59334844 P275 Q59334844-5cfc0ff4-6537-4cc4-8782-b0980e96a890 @default.
- Q59334844 P304 Q59334844-0B038888-AD65-4A1C-811B-5D4B41888A0B @default.
- Q59334844 P31 Q59334844-94F7D459-8AA5-4B15-BBE1-4157496D24BB @default.
- Q59334844 P356 Q59334844-4C712AAE-2C92-4203-A014-01FC1C110A30 @default.
- Q59334844 P433 Q59334844-328F3D03-C56D-4993-B41C-AB775EE180BB @default.
- Q59334844 P478 Q59334844-ACBFC864-2F32-43B5-AD6D-0DFA20D1253B @default.
- Q59334844 P50 Q59334844-5F496B7C-5884-43C6-BF00-0FD195B87370 @default.
- Q59334844 P50 Q59334844-EB460065-4235-4D20-9600-410474CA5F45 @default.
- Q59334844 P577 Q59334844-FE2A0BC3-ABBC-4AEB-9116-64B5234ECA3A @default.
- Q59334844 P6216 Q59334844-d0d7c89e-0dd0-4e3e-ad18-c1c088beb65d @default.
- Q59334844 P921 Q59334844-CA58371F-920D-4974-9CDA-6DFE364B64C7 @default.
- Q59334844 P932 Q59334844-AE94B2E8-BB21-462D-8D63-77ABFF96B8C3 @default.
- Q59334844 P356 OFY209.170 @default.
- Q59334844 P1433 Q27725953 @default.
- Q59334844 P1476 "2562. Re-Appraisal of Aminoglycoside (AG) Susceptibility Testing Breakpoints Based on the Application of Pharmacokinetics–Pharmacodynamics (PK-PD) and Contemporary Microbiology Surveillance Data" @default.
- Q59334844 P2093 "David R Andes" @default.
- Q59334844 P2093 "Jeffrey P Hammel" @default.
- Q59334844 P2093 "John S Bradley" @default.
- Q59334844 P2093 "Nikolas J Onufrak" @default.
- Q59334844 P2093 "Paul G Ambrose" @default.
- Q59334844 P2093 "Sujata M Bhavnani" @default.
- Q59334844 P275 Q24082749 @default.
- Q59334844 P304 "S71-S71" @default.
- Q59334844 P31 Q13442814 @default.
- Q59334844 P356 "10.1093/OFID/OFY209.170" @default.
- Q59334844 P433 "suppl_1" @default.
- Q59334844 P478 "5" @default.
- Q59334844 P50 Q120908182 @default.
- Q59334844 P50 Q63144550 @default.
- Q59334844 P577 "2018-11-01T00:00:00Z" @default.
- Q59334844 P6216 Q50423863 @default.
- Q59334844 P921 Q725307 @default.
- Q59334844 P932 "6252396" @default.